We’ve recommended a new treatment called rozanolixizumab for some adults living with generalised myasthenia gravis (gMG) whose symptoms are not controlled by existing treatments.
UK NICE · April 29, 2026
NICE recommendation: rozanolixizumab for uncontrolled generalised myasthenia gravis
Original title: First NICE recommended treatment for uncontrolled generalised myasthenia gravis
NICE recommends rozanolixizumab for adults with generalised myasthenia gravis uncontrolled by existing treatments.
Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.